Dr. Schertzer is primarily interested in droplet based microfluidic technologies for applications in point of care medical diagnostics, multiphase heat transfer and energy generation. His ...
A new analysis method based on digital microfluidics developed by researchers at the University of Toronto (U of T) Institute of Biomaterials and Biomedical Engineering could eventually eliminate the ...
A research paper by scientists at Beijing Institute of Technology and City University of Hong Kong presented a versatile electrodynamics simulation model designed to analyze the driving forces of ...
Oak Brook, IL – The February 2023 issue of SLAS Technology contains a set of four original research articles and one review article covering digital microfluidics (DMF), cryopreservation, colorectal ...
(Nanowerk Spotlight) Microfluidics, the science of manipulating tiny amounts of fluid in micro-scale devices, has long held promise for revolutionizing fields like medical diagnostics, chemistry, and ...
Digital SPR TM is a next-generation technology for characterizing biomolecular interactions. By combining digital microfluidics (DMF) with SPR, digital SPR systems can effectively bypass common ...
Microfluidics Market to Reach $77.5 Billion, Globally, by 2033 at 13.7% CAGR: Allied Market Research
Allied Market Research published a report, titled, "Microfluidics Market by Application (Medical/Healthcare and Non-Medical), Material (Silicone, Glass, Polymer, PDMS, and Others), Technology ...
CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...
Digital microfluidics and biochip technologies represent a rapidly evolving interdisciplinary field that integrates principles of physics, chemistry and engineering to manipulate discrete droplets ...
Drug developers are consistently aiming to enhance clinical relevance in drug discovery. CRISPR has emerged as a versatile tool to accelerate the entire drug discovery process, with arrayed CRISPR ...
When synthesizing nanoscale liposomes, the ability to control vesicle size helps define their pharmaceutical properties. Conventional microfluidic liposome synthesis methods, however, are limited in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results